Kardex Holding AG
Kardex Holding AG (KARN.SW) Financial Performance & Income Statement Overview
Analyze Kardex Holding AG (KARN.SW) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Kardex Holding AG (KARN.SW) Income Statement & Financial Overview
Review Kardex Holding AG KARN.SW income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $421.50M | $369.70M | $368.40M | $334.50M |
| Cost of Revenue | $272.00M | $242.40M | $243.40M | $223.60M |
| Gross Profit | $149.50M | $127.30M | $125.00M | $110.90M |
| Gross Profit Ratio | $0.35 | $0.34 | $0.34 | $0.33 |
| R&D Expenses | $12.00M | $10.50M | $10.00M | $7.50M |
| SG&A Expenses | $82.90M | $68.20M | $67.50M | $59.70M |
| Operating Expenses | $99.30M | $79.10M | $82.60M | $67.80M |
| Total Costs & Expenses | $371.30M | $321.50M | $326.00M | $291.40M |
| Interest Income | $2.50M | $2.40M | $1.80M | $200000.00 |
| Interest Expense | $300000.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $8.80M | $4.90M | $2.00M | $4.50M |
| EBITDA | $64.40M | $53.10M | $49.20M | $47.60M |
| EBITDA Ratio | $0.15 | $0.14 | $0.13 | $0.14 |
| Operating Income | $50.20M | $48.20M | $47.20M | $43.10M |
| Operating Income Ratio | $0.12 | $0.13 | $0.13 | $0.13 |
| Other Income/Expenses (Net) | $2.70M | $2.40M | -$3.00M | -$200000.00 |
| Income Before Tax | $52.90M | $50.60M | $44.20M | $42.90M |
| Income Before Tax Ratio | $0.13 | $0.14 | $0.12 | $0.13 |
| Income Tax Expense | $10.40M | $12.30M | $9.70M | $10.50M |
| Net Income | $42.50M | $38.20M | $34.40M | $32.20M |
| Net Income Ratio | $0.10 | $0.10 | $0.09 | $0.10 |
| EPS | $5.50 | $4.95 | $4.46 | $4.17 |
| Diluted EPS | $5.50 | $4.95 | $4.46 | $4.17 |
| Weighted Avg Shares Outstanding | $7.72M | $7.72M | $7.71M | $7.72M |
| Weighted Avg Shares Outstanding (Diluted) | $7.72M | $7.72M | $7.71M | $7.71M |
Over the past four quarters, Kardex Holding AG demonstrated steady revenue growth, increasing from $334.50M in Q2 2023 to $421.50M in Q4 2024. Operating income reached $50.20M in Q4 2024, maintaining a consistent 12% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $64.40M, reflecting operational efficiency. Net income rose to $42.50M, with EPS at $5.50. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan